Page 4 - மகில் பல்கலைக்கழகம் நகை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மகில் பல்கலைக்கழகம் நகை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மகில் பல்கலைக்கழகம் நகை Today - Breaking & Trending Today

Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Europe Until 2033

Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Europe Until 2033
March 11, 2021 09:00 ET
| Source:
Sunshine Biopharma Inc.
Sunshine Biopharma Inc.
Montreal, Quebec, CANADA
MONTREAL, March 11, 2021 (GLOBE NEWSWIRE) Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs today announced that it has received a “Notice of Allowance” from the European Patent Office for a new patent application covering Adva-27a, the Company’s flagship anticancer compound. This newly issued patent contains new subject matter and extends the proprietary protection of Adva-27a in Europe until 2033. The equivalent patent in the United States was issued in 2019 (US Patent Number 10,272,065) and similarly covers Adva-27a until 2033. The Canadian Intellectua ....

United States , Steven Slilaty , European Patent Office , Sunshine Biopharma Inc , Mcgill University Jewish , European Union , Canadian Intellectual Property , Sunshine Biopharma , Multidrug Resistant Cancer Cells , Pancreatic Cancer , Small Cell Lung Cancer , Breast Cancer , Uterine Sarcoma , Mcgill University , Jewish General Hospital , Otcbb Sbfm , Cancer Patent , Phamaceutical Research Center , Healthcare And Hospitals , ஒன்றுபட்டது மாநிலங்களில் , ஐரோப்பிய காப்புரிமை அலுவலகம் , மகில் பல்கலைக்கழகம் நகை , ஐரோப்பிய தொழிற்சங்கம் , கனடியன் அறிவுசார் ப்ராபர்டீ , கணையம் புற்றுநோய் , சிறிய செல் நுரையீரல் புற்றுநோய் ,

Sunshine Biopharma Discusses the Progress of Its COVID-19 and Anticancer Compounds with The Stock Day Podcast

(MENAFN - Newsfile Corp) Sunshine Biopharma Discusses the Progress of Its COVID-19 and Anticancer Compounds with The Stock Day Podcast
Phoenix, Arizona (Newsfile Corp. - February 17, 2021) - The Stock Day Podcast welcomed Sunshine Biopharma (OTC Pink: SBFM) ( the Company ), a company engaged in the development of Adva-27a, a unique anticancer compound, as well as the development of a treatment for COVID-19. CEO of the Company, Dr. Steve Slilaty, joined Stock Day host, Everett Jolly.
Jolly began the interview by commenting on the Company s significant increase in stock price over the past several months. I think the market recognizes the significant progress that we ve been making, and we re very excited about the science we ve been doing, shared Dr. Slilaty. ....

United States , Camille Sebaaly , Everett Jolly , Steve Slilaty , Arizona Newsfile Corp , Exchange Commission , Sunshine Biopharma Inc , Mcgill University Jewish , University Of Georgia , Sunshine Biopharma Discusses , Anticancer Compounds , Stock Day Podcast , Sunshine Biopharma , Stock Day , Stock Day Media , Multidrug Resistant Cancer Cells , Pancreatic Cancer , Small Cell Lung Cancer , Breast Cancer , Uterine Sarcoma , Mcgill University , Jewish General Hospital , Additional Information Contact , Bio Pharma , Covid 19 , Anti Cancer ,

Sunshine Biopharma Initiates COVID-19 Treatment Mice Study

Press release content from Accesswire. The AP news staff was not involved in its creation. ....

Camille Sebaaly , Steve Slilaty , Exchange Commission , Sunshine Biopharma Inc , Mcgill University Jewish , College Of Pharmacy , University Of Georgia , Sunshine Biopharma , Acute Respiratory , Multidrug Resistant Cancer Cells , Pancreatic Cancer , Small Cell Lung Cancer , Breast Cancer , Uterine Sarcoma , Mcgill University , Jewish General Hospital , Additional Information Contact , Products And Services , Coronavirus Pandemic , Product Testing , Severe Acute Respiratory Syndrome , Pharmaceutical Manufacturing , Health Care Industry , Lung Disease , New Products And Services , Medical Research ,

Sunshine Biopharma Signs Exclusive License Agreement With University of Georgia for COVID-19 Compounds

Sunshine Biopharma Signs Exclusive License Agreement With University of Georgia for COVID-19 Compounds
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.

Steven Slilaty , Camille Sebaaly , Exchange Commission , Sunshine Biopharma Inc , Mcgill University Jewish , University Of Georgia , Sunshine Biopharma , Acute Respiratory , Multidrug Resistant Cancer Cells , Pancreatic Cancer , Small Cell Lung Cancer , Breast Cancer , Uterine Sarcoma , Mcgill University , Jewish General Hospital , Additional Information Contact , பரிமாற்றம் தரகு , மகில் பல்கலைக்கழகம் நகை , பல்கலைக்கழகம் ஆஃப் ஜார்ஜியா , எடுப்போசை சுவாச , கணையம் புற்றுநோய் , சிறிய செல் நுரையீரல் புற்றுநோய் , மார்பக புற்றுநோய் , கருப்பை சர்கோமா , மகில் பல்கலைக்கழகம் , நகை ஜநரல் மருத்துவமனை ,

Sunshine Biopharma Inc.: Sunshine Biopharma Signs Exclusive License Agreement With University of Georgia for COVID-19 Compounds

(1)
MONTREAL, QC / ACCESSWIRE / February 4, 2021 / Sunshine Biopharma Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs today announced that it has signed an exclusive license agreement with the University of Georgia ( UGA ) for two Anti-Coronavirus compounds which UGA had previously developed and patented. Sunshine Biopharma and UGA will advance the development of these two compounds in parallel with Sunshine Biopharma s own SBFM-PL4. The next step in the development plan involves testing of the efficacy of these compounds in transgenic mice. Mice which have been genetically engineered to become susceptible to infection by SARS-CoV-2, the causative agent of COVID-19, will be challenged with the virus and subsequently treated with the test compounds to determine if progression to diseases can be arrested. Such studies are anticipated to be underway later this month. ....

Kostenloser Wertpapierhandel , Steven Slilaty , Camille Sebaaly , Exchange Commission , Sunshine Biopharma Inc , Mcgill University Jewish , University Of Georgia , Sunshine Biopharma , Acute Respiratory , Multidrug Resistant Cancer Cells , Pancreatic Cancer , Small Cell Lung Cancer , Breast Cancer , Uterine Sarcoma , Mcgill University , Jewish General Hospital , Additional Information Contact , பரிமாற்றம் தரகு , மகில் பல்கலைக்கழகம் நகை , பல்கலைக்கழகம் ஆஃப் ஜார்ஜியா , எடுப்போசை சுவாச , கணையம் புற்றுநோய் , சிறிய செல் நுரையீரல் புற்றுநோய் , மார்பக புற்றுநோய் , கருப்பை சர்கோமா , மகில் பல்கலைக்கழகம் ,